Dr. Sophie Allauzen has 20 years of international experience in R&D, business development, and portfolio management in various diagnostic industries managing the full life-cycle of novel diagnostic products (R&D, planning,commercialization, and registration) in developed and developing worlds.Sophie’s experience includes the Bill & Melinda Gates Foundation where she oversaw malaria and a portfolio of neglected diseases diagnostic programs,Novartis Diagnostics as Head of Blood Testing running the NAT/Immunohematology product portfolio, and Bio-Rad managing the R&D department for the development of bead multi-array immuno-assays. Prior moving to the U.S., Sophie spent five years at Sanofi Diagnostics Pasteur in France, in R&D working on the development of various tests for infectious diseases.
Sophie holds a PhD in biochemistry/immunology from Montpellier University, France,directed toward auto-immune disease mechanisms, and completed her postdoc fellow position in allergy at University of Minnesota.
She is currently an independent consultant based in San Francisco, CA.
Sophie serves as a technical advisor for Stop the Spread, with a focus on diagnostics.